October 24, 2025

Synbiotic Supplement Reduced Multiple Inflammatory Proteins

Butyrate rise corresponded with lower IL-6 during 6-week synbiotic supplementation.

Conexiant

October 23, 2025

Nutritional IBD screening tools ranked

Single-center cohort finds MIRT most sensitive at predicting malnutrition or low Fat-Free Mass Index within six months in patients in remission with IBD; SaskIBD-NR shows the highest accuracy for GLIM-defined malnutrition and for low Fat-Free Mass Index.

Conexiant

October 22, 2025

Do GLP-1RAs Differ in Cardiometabolic Protection?

Researchers found that liraglutide and semaglutide offer similar cardiovascular and kidney benefits in type 2 diabetes.

Conexiant

October 20, 2025

FDA Okays First Oral GLP-1 for CV Risk

Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.

Conexiant

October 20, 2025

ACP Backs Single CRC Screening Metric

Performance committee rejects four measures over evidence misalignment and methodological concerns.

Conexiant

October 16, 2025

Needles and Pills: Painless Oral Protein Delivery

Researchers at the University of Bath are bringing the vision of pills as an alternative to injections for life-saving biologics closer to reality.

The Medicine Maker

October 15, 2025

Study Describes Patterns in Reported Drug Interactions

Researchers analyze about 177,000 drug interactions to identify key medication safety trends.

Conexiant

October 15, 2025

‘Covered.’ ‘Authorized.’ Prescribed? 

'Covered,’ yes. But who’s actually getting GLP-1s—and why so few scripts?

KFF Health News

October 08, 2025

New Data Tie GLP-1 Therapies to GERD

"These potential risks should be weighed against the established clinical benefits of this drug class."

Conexiant